Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1

Status

Completed 4Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Motor Activity 1Melanoma 1Liver Neoplasms 1Hyperphagia 1Fibrosis 1Disease Progression 1Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 1488Cisplatin 1410Paclitaxel 1316Radiotherapy 1259Carboplatin 1247Gemcitabine 1214Docetaxel 1110Bevacizumab 1029Fluorouracil 894Doxorubicin 786Dexamethasone 746Rituximab 719Capecitabine 716Oxaliplatin 700pembrolizumab 673Etoposide 673Irinotecan 634Filgrastim 621Cytarabine 584Leucovorin 578Nivolumab 557Vincristine 510Prednisone 474Cetuximab 464Bortezomib 457Erlotinib Hydrochloride 456Trastuzumab 448Methotrexate 437Lenalidomide 426Pemetrexed 419

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Interventional × Clinical Trials as Topic × Clear all
NCT02645149 2026-02-27

Match Mel

Melanoma Institute Australia

Phase 2 Completed
216 enrolled
Dermatologic

Melanoma

NCT02376231 2019-09-26

PJEOC

Royal Surrey County Hospital NHS Foundation Trust

Phase NA Completed
120 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

NCT02321202 2018-08-22

Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer

Huazhong University of Science and Technology

Phase 4 Completed
320 enrolled
Gastrointestinal

Fibrosis, Hyperphagia, Liver Neoplasms, Disease Progression

NCT01571401 2013-06-19

TRACKS

University of Alberta

Phase 2 Completed
32 enrolled

Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡